InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: The oNiOnHEAd post# 73658

Saturday, 05/02/2020 11:27:54 PM

Saturday, May 02, 2020 11:27:54 PM

Post# of 232947
For starters, the FDA letter only applies to patients on oxygen with SpO2 <94%.

Second, RDV won't be available to blanket the country in a day. Current trials will have a window to enroll.

Third, your concern will indeed be addressed in future trials:, which wil be (RDV+another drug) vs. (RDV only). There will be no problem picking up the leronlimab signal in such a trial.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News